Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Clinical Application of a Novel Radiolabeled Translocator Protein (TSPO) Targeted Small Molecular Probe in Neuroinflammation Imaging of Alzheimer's Disease.

Authors not listed

Nanjing First Hospital, Nanjing Medical University · 2025

Abstract

Evaluate the clinical application value of the novel radiolabeled TSPO-targeted molecular probe Gallium \[68Ga\]-DOTA-HK-011 in neuroinflammation imaging of Alzheimer's disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-26 MST

Cite this

APA
Anonymous. (2025). Clinical Application of a Novel Radiolabeled Translocator Protein (TSPO) Targeted Small Molecular Probe in Neuroinflammation Imaging of Alzheimer's Disease. <em>Nanjing First Hospital, Nanjing Medical University</em>. https://clinicaltrials.gov/study/NCT07105956
Vancouver
Anonymous. Clinical Application of a Novel Radiolabeled Translocator Protein (TSPO) Targeted Small Molecular Probe in Neuroinflammation Imaging of Alzheimer's Disease. Nanjing First Hospital, Nanjing Medical University. 2025.
BibTeX
@misc{anon2025Clinic, title = {Clinical Application of a Novel Radiolabeled Translocator Protein (TSPO) Targeted Small Molecular Probe in Neuroinflammation Imaging of Alzheimer's Disease.}, author = {Anonymous}, journal = {Nanjing First Hospital, Nanjing Medical University}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings